ClinicalTrials.Veeva

Menu

Evaluation of Immunogenicity of COVID-19 Vaccine in Chinese Population

A

Air Force Military Medical University of People's Liberation Army

Status

Completed

Conditions

COVID

Treatments

Other: No Interventions

Study type

Observational

Funder types

Other

Identifiers

NCT06763887
KY20232379-C-1

Details and patient eligibility

About

The purpose of this study is to evaluate the immunogenicity and immune protection of COVID-19, especially the recently prevalent strains, against the background of current immunization in Chinese population

Enrollment

100 patients

Sex

All

Ages

18 to 75 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. He was infected with COVID-19 from November to December 2022;
  2. Have not been infected with COVID-19 (the subject said that he was not infected and signed the informed consent form);
  3. Those who agree and sign the informed consent form.

Exclusion criteria

  1. Missing or incomplete questionnaires that affect research results;
  2. Individuals with combined dysfunction of important organs such as the heart, liver, and lungs;
  3. Mental and behavioral abnormalities;
  4. Intellectual disability;
  5. Under 18 years old or over 75 years old;
  6. Low understanding and communication skills.

Trial design

100 participants in 1 patient group

Observation
Treatment:
Other: No Interventions

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems